| 09:55~10:00 |
Opening |
| 10:00~11:00 |
Jeonbuk Company Introduction (IR) |
Medicosbiotech CEO |
Soon Cheol KIM |
|
|
| MediNResearch CEO |
Seo Hyung LEE |
|
|
| ViEL-T CEO |
Sangmin KANG |
|
|
| Basgenbio CEO |
Ho KIM |
|
|
| Plasbio CEO |
Sung Gurl PARK |
|
|
| 11:00~11:30 |
AI Bio Healthcare R&D Trends |
ETRI Director |
Soo Jun PARK |
|
|
| 11:30~12:00 |
Advanced cell culture technology based on functional polymer thin films for the development of cell therapy products |
KAIST professor |
Sung Gap IM |
|
|
| 12:00~12:30 |
Introducing NAMSA's Solution for FDA Medical Device Certification |
MD Science Director |
Sun Young PARK |
|
|
| 12:30~14:00 |
Luncheon Meeting |
| 14:00~14:30 |
Navigating Regulatory and CMC Challenges in Cell & Gene Therapy Development |
KHIDI Senior Consultant |
Jun T. Park |
|
|
| 14:30~15:00 |
Current status of advanced materials-based biomaterial technology |
KIST Head |
Hojeong JEON |
|
|
| 15:00~15:20 |
Break Time |
| 15:20~15:50 |
Legal Issues in Biodata Information Protection in the Global AI Era |
Sejong University professor of Law, Attorney at Law |
Sungjai CHOI |
|
|
| 15:50~17:00 |
Networking |
